Former writer for The Motley Fool specializing in the finance of healthcare, technology, and retail.
Customer Ratings
0
$1.39K
Earned
5
Customer Favorites
Writing samples by Brandy B ...
Statins Beware?
When best-selling cholesterol drug Lipitor fell off the patent cliff in 2011, the question became, "What's next?" A hot new class of treatments called PCSK9 inhibitors want to become the answer...
Brandy B writes about...
- Health
- Pcsk9
- Alirocumab
- Atorvastatin
- Ezetimibe
- Statin
- Medicine
- Life sciences industry
- Drugs
- Pharmacology
- Medical treatments
- Clinical medicine
- Medical specialties
- Pharmaceutical industry
- Organic compounds
- Hypolipidemic agents
- Regeneron
- Pharmaceutical sciences
- Cholesterol
- Entertainment
- Business
- Healthcare and sciences
- Software
- Technology
- Healthcare
- Pharmaceuticals
- Healthcare management
- Science
Topics
Looking to Hire Other Writers Like Brandy B?
Brandy B creates content for these topics. Select a topic to browse other writers on our platform that also write about that topic.
